Park Yong Hyun, Kwon Oh Seong, Hong Sung-Hoo, Kim Sae Woong, Hwang Tae-Kon, Lee Ji Youl
Department of Urology, Seoul St. Mary's Hospital, The Catholic University of Korea School of Medicine, Seoul, Korea.
Int Neurourol J. 2016 Mar;20(1):69-74. doi: 10.5213/inj.1630428.214. Epub 2016 Mar 16.
We aimed to assess whether nerve-sparing radical prostatectomy (nsRP) is associated with improved recovery of urinary continence compared to non-nerve-sparing radical prostatectomy (nnsRP) in patients with localized prostate cancer and preoperative erectile dysfunction.
A total of 360 patients with organ-confined prostate cancer and an International Index of Erectile Function score of less than 17 were treated with nsRP or nnsRP in Seoul St. Mary's Hospital. Patients who received neoadjuvant or adjuvant androgen deprivation therapy or had a history of prostate-related surgery were excluded. Recovery of urinary continence was assessed at 0, 1, 3, 6, and 12 months. Postoperative recovery of continence was defined as zero pad usage. The association between nerve-sparing status and urinary continence was assessed by using univariate and multivariate Cox regression analyses after controlling for known predictive factors.
Urinary continence recovered in 279 patients (77.5%) within the mean follow-up period of 22.5 months (range, 6-123 months). Recovery of urinary continence was reported in 74.6% and 86.4% of patients after nnsRP and nsRP, respectively, at 12 months (P=0.022). All groups had comparable perioperative criteria and had no significant preoperative morbidities. Age, American Society of Anesthesiologists score, and nerve-sparing status were significantly associated with recovery of urinary continence on univariate analysis. On multivariate analysis, age (hazard ratio [HR], 1.254; 95% confidence interval [CI], 1.002-1.478; P=0.026) and nerve-sparing status (HR, 0.713; 95% CI, 0.548-0.929; P=0.012) were independently associated with recovery of urinary continence.
nsRP, as compared to nnsRP, improves recovery rates of urinary incontinence and decreases surgical morbidity without compromising pathologic outcomes.
我们旨在评估在局限性前列腺癌且术前存在勃起功能障碍的患者中,与非保留神经的根治性前列腺切除术(nnsRP)相比,保留神经的根治性前列腺切除术(nsRP)是否与尿失禁恢复情况改善相关。
首尔圣玛丽医院对总共360例器官局限性前列腺癌且国际勃起功能指数评分低于17的患者进行了nsRP或nnsRP治疗。排除接受新辅助或辅助雄激素剥夺治疗或有前列腺相关手术史的患者。在0、1、3、6和12个月时评估尿失禁的恢复情况。术后尿失禁恢复定义为无需使用尿垫。在控制已知预测因素后,通过单因素和多因素Cox回归分析评估保留神经状态与尿失禁之间的关联。
在平均22.5个月(范围6 - 123个月)的随访期内,279例患者(77.5%)恢复了尿失禁。在12个月时,nnsRP和nsRP术后分别有74.6%和86.4%的患者恢复了尿失禁(P = 0.022)。所有组围手术期标准相当,术前无显著合并症。单因素分析显示,年龄、美国麻醉医师协会评分和保留神经状态与尿失禁恢复显著相关。多因素分析显示,年龄(风险比[HR],1.254;95%置信区间[CI],1.002 - 1.478;P = 0.026)和保留神经状态(HR,0.713;95% CI,0.548 - 0.929;P = 0.012)与尿失禁恢复独立相关。
与nnsRP相比,nsRP可提高尿失禁的恢复率,降低手术并发症发生率,且不影响病理结果。